Aether Biomedical

Aether Biomedical, established in 2018, is at the forefront of healthcare technology and robotics, underpinned by a human-centered design philosophy. With its headquarters in Poland and a strategic expansion into Europe and Asia, the company is now entering the U.S. market with its new U.S. base in Chicago, IL.

Their flagship product, the Zeus hand, stands out as the world's strongest multi-articulating myoelectric hand, offering 30-40% more grip force compared to current market competitors. Its groundbreaking impact resistance mechanism provides unparalleled durability, with the unique advantage of being repairable in under 15 minutes. The device is highly customizable with 12 grip patterns.

In November 2023, Aether Biomedical secured a $5.80M Series A investment, backed by Chiratae Ventures, Story Ventures, and J2 Ventures. This funding positions the company to accelerate growth and enhance its digital ecosystem, enriching patient experiences through advanced analytics and seamless integration.